(Q37591139)

21 August 2017

Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival (English)

1 reference

non-small-cell lung carcinoma

21 August 2017

1 reference

Yan Li

1

1 reference

21 August 2017

Michael J Krowka

2

1 reference

21 August 2017

Yingwei Qi

3

1 reference

21 August 2017

Jerry A Katzmann

4

1 reference

21 August 2017

Yong Song

5

1 reference

21 August 2017

Yafei Li

6

1 reference

21 August 2017

Sumithra J Mandrekar

7

1 reference

21 August 2017

Ping Yang

8

1 reference

21 August 2017

1 February 2011

1 reference

Journal of Thoracic Oncology

21 August 2017

1 reference

21 August 2017

6

1 reference

21 August 2017

2

1 reference

21 August 2017

291-295

1 reference

21 August 2017

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

Alpha1-antitrypsin deficiency

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

Alpha-1 antitrypsin deficiency in emphysema

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

Alpha1-antitrypsin deficiency: biological answers to clinical questions

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

An evaluation of the prognostic significance of alpha-1-antitrypsin expression in adenocarcinomas of the lung: an immunohistochemical analysis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

Acute-phase reactant protein profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

Acute phase reactant proteins in prostatic cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

Alpha1-antitrypsin inhibits angiogenesis and tumor growth

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

Alpha1-antitrypsin deficiency and inflammatory bowel diseases.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

Recent pulmonary observations in alpha 1-antitrypsin deficiency, primary biliary cirrhosis, chronic hepatitis C, and other hepatic problems

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

Regulation of alpha1-proteinase inhibitor release by proinflammatory cytokines in human intestinal epithelial cells.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

Alpha 1-antitrypsin and cancer of the pancreas

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3927968

Plasma Alpha-1-Antitrypsin Levels in Early and Late Carcinoma of the Cervix

1 September 2018

1 reference

12 December 2020

Serum alpha1-antitrypsin in patients with lung cancer or abnormal sputum cytology

1 reference

12 December 2020

Alfa-antitrypsin increase in lung cancer

1 reference

12 December 2020

Alpha 1-antitrypsin, alpha 1-antichymotrypsin, and alpha 2-macroglobulin in human gastric carcinomas: a retrospective immunohistochemical study

1 reference

12 December 2020

Acute phase proteins and recombinant IL-2 therapy: prediction of response and survival in patients with colorectal cancer

1 reference

12 December 2020

Does the concentration of alpha 1-proteinase inhibitor reflect the transformation of liver cirrhosis to liver carcinoma?

1 reference

12 December 2020

Alpha1-antitrypsin deficiency allele carriers among lung cancer patients

1 reference

12 December 2020

Alpha-1-antitrypsin and its relevance to human disease

1 reference

12 December 2020

Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003

1 reference

12 December 2020

10.1097/JTO.0B013E31820213FB

Identifiers

DOI

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

21173712

1 reference